Nova Leap Health (TSXV:NLH) ROCE % : -2.70% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Nova Leap Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nova Leap Health's annualized ROCE % for the quarter that ended in Sep. 2024 was -2.70%.

Nova Leap Health ROCE % Historical Data

The historical data trend for Nova Leap Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Leap Health ROCE % Chart

Nova Leap Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-15.96

-5.79

4.99

16.95

-4.76

Nova Leap Health Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-5.07	10.87	11.99	7.17	-2.70

Nova Leap Health ROCE % Calculation

Nova Leap Health's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-1.272	/	( ( (34.264 - 7.971)	+	(32.535 - 5.418) )	/ 2 )
	=	-1.272	/	( (26.293	+	27.117)	/ 2 )
	=	-1.272	/	26.705
	=	-4.76 %

Nova Leap Health's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-0.704	/	( ( (28.75 - 2.511)	+	(28.505 - 2.568) )	/ 2 )
	=	-0.704	/	( ( 26.239	+	25.937 )	/ 2 )
	=	-0.704	/	26.088
	=	-2.70 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Nova Leap Health (TSXV:NLH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nova Leap Health ROCE % Related Terms

Thank you for viewing the detailed overview of Nova Leap Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Leap Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nova Leap Health Corp (TSXV:NLH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

NVLPF:USA

Address

7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2

Website

https://www.novaleaphealth.com

Nova Leap Health Corp operates in the healthcare industry. The company is a provider of personal home care and support services. The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offering includes meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S operations. The company derives a majority of its revenue from the United States.

Executives

Christopher Donald Dobbin	Director, Senior Officer
R. Wayne Myles	Director
Christopher Thomas Francis Leblanc	Senior Officer
Lisette France Hachey	Senior Officer
Megan Gail Spidle	Senior Officer
Michael Austin O'keefe	Director
Dana Murray Hatfield	Director

Nova Leap Health Headlines

No Headlines